International Anesthesia Research Society (IARS) Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2003
NCT00197340
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

lidocaine (xylocaine) (1 trial)

ropivacaine (naropin) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eclampsia (Phase 3)

Fetal Growth Retardation (Phase 3)

Pre-Eclampsia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3